Names and Identifiers

• • Indoramin
  • 3-[2-(4-benzamido-1-piperidyl)ethyl]indole
  • INDORAMIN, CRM STANDARD
  • Indoramine
  • Indoramine-D5
  • N-[1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl]benzamide
  • 3-[2-(4-benzamidopiperid-1-yl)ethyl]indole
  • 3-<2-(4-Benzamidopiperid-1-yl)ethyl>indol
  • Benzamide,N-(1-(2-(1H-indol-3-yl)ethyl)-4-piperidinyl)
  • EINECS 248-041-5
  • Indoramina [INN-Spanish]
  • Indoramine [INN-French]
  • Indoraminum [INN-Latin]
  • N-[1-(2-indol-3-yl-ethyl)-piperidin-4-yl]-benzamide
  • PDSP1_001423
  • SCHEMBL49518
  • DTXSID7048370
  • DB08950
  • N-{1-[2-(1H-Indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide(Indoramin)
  • Indoraminum
  • Benzamide, N-(1-(2-indol-3-ylethyl)-4-piperidyl)-
  • N-(1-(2-(1H-Indol-3-yl)ethyl)-4-piperidinyl)benzamide
  • Indoramine;Wy 21901
  • HMS1445B22
  • INDORAMINN-{1-[2-(1H-Indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide
  • L001292
  • 3-[2-(4-Benzamidopiperidino)ethyl]indole
  • Baratol
  • NSC-771684
  • D04531
  • N-(1-[2-(1H-Indol-3-yl)ethyl]-4-piperidinyl)benzamide #
  • 0Z802HMY7H
  • BRN 0494035
  • CS-0012358
  • CHEMBL279516
  • NCGC00165810-01
  • AKOS015994528
  • N-{1-[2-(1H-Indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide
  • Indoramin [USAN:INN:BAN]
  • 3-(2-(4-Benzamidopiperid-1-yl)ethyl)indole
  • GTPL501
  • Q408963
  • Benzamide, N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidinyl]-
  • NS00003913
  • SCHEMBL49517
  • PDSP2_001407
  • IDI1_016359
  • Wy-21901
  • INDORAMIN [INN]
  • CCG-41146
  • BDBM50033113
  • SR-01000631243-1
  • Indoramina
  • INDORAMIN [MI]
  • Oprea1_130443
  • Maybridge3_004972
  • CHEBI:135470
  • Benzamide, N-(1-(2-(1H-indol-3-yl)ethyl)-4-piperidinyl)-
  • MLS001182179
  • HMS2851P23
  • INDORAMIN [WHO-DD]
  • NSC771684
  • SMR000567879
  • N-{1-[2-(1H-Indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide (Indoramin)
  • N-[1-(2-Indol-3-ylethyl)-4-piperidyl]benzamide
  • PDSP2_001083
  • AF-0013
  • PDSP1_001099
  • Benzamide, N-[1-(2-indol-3-ylethyl)-4-piperidyl]-
  • UNII-0Z802HMY7H
  • WY 21901
  • 26844-12-2
  • Doralese
  • Indoramin (USAN/INN)
  • HY-12760
  • N-(1-(2-Indol-3-ylethyl)-4-piperidyl)benzamide
  • INDORAMIN [USAN]
  • BRD-K76953762-001-08-5
  • DB-315015
  • SBI-0653871.0001
  • N-(1-(2-(1H-indol-3-yl)ethyl)piperidin-4-yl)benzamide
  • Indoraminum (INN-Latin)
  • Indoramine (INN-French)
  • Indoramina (INN-Spanish)
  • Doralese tiltab
  • DTXCID3028344
  • 248-041-5
  • C02CA02
  • Wy21901
  • +expand
• • Inchi： 1S/C22H25N3O/c26-22(17-6-2-1-3-7-17)24-19-11-14-25(15-12-19)13-10-18-16-23-21-9-5-4-8-20(18)21/h1-9,16,19,23H,10-15H2,(H,24,26)
  • InChI Key： JXZZEXZZKAWDSP-UHFFFAOYSA-N
  • SMILES： O=C(C1C=CC=CC=1)NC1CCN(CCC2=CNC3C=CC=CC2=3)CC1

Computed Properties

Experimental Properties